PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Conditions: Metastatic Colon Cancer Interventions: Drug: Serplulimab, mFOLFOX6 Sponsors: Henan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Hospitals | Neoadjuvant Therapy | Research